These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 25930686)

  • 1. Recurrent Clostridium difficile infection: From colonization to cure.
    Shields K; Araujo-Castillo RV; Theethira TG; Alonso CD; Kelly CP
    Anaerobe; 2015 Aug; 34():59-73. PubMed ID: 25930686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the management of recurrent Clostridioides difficile infection.
    Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
    Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiologic factors affecting Clostridium difficile recurrence.
    Chilton CH; Pickering DS; Freeman J
    Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
    Okafor CM; Clogher P; Olson D; Niccolai L; Hadler J
    Emerg Infect Dis; 2023 May; 29(5):877-87. PubMed ID: 37081745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.
    Zainul NH; Ma ZF; Besari A; Siti Asma H; Rahman RA; Collins DA; Hamid N; Riley TV; Lee YY
    Epidemiol Infect; 2017 Oct; 145(14):3012-3019. PubMed ID: 28891459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
    Madoff SE; Urquiaga M; Alonso CD; Kelly CP
    Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent
    Song JH; Kim YS
    Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
    Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 - 2019: the RECUR Germany study.
    Tricotel A; Antunes A; Wilk A; Dombrowski S; Rinta-Kokko H; Andersson FL; Ghosh S
    BMC Infect Dis; 2024 Mar; 24(1):357. PubMed ID: 38539166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for recurrent
    Baldassarre L; Quach-Thanh C; Mouajou Feujio V; Tadount F; Deyirmendjian C; Lefebvre MA; Thampi N; Schneider O; Fabri-Karam I; O'Donnell S; Okeny-Owere J; Audy N; Desmarais N
    Infect Control Hosp Epidemiol; 2024 Feb; 45(2):182-187. PubMed ID: 37700539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
    Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
    Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.